Skip to Content

93 7220 (Topiramate 200 mg)

Pill with imprint 93 7220 is Pink, Capsule-shape and has been identified as Topiramate 200 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7220

Topiramate 200 mg 93 7220
Topiramate 200 mg 93 7220
Topiramate 200 mg 93 7220

Topiramate

Imprint
93 7220
Strength
200 mg
Color
Pink
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 4000, corn starch, sodium starch glycolate type A potato, titanium dioxide, hypromellose 2910 (15 mPa.s), polydextrose, ferric oxide red, FD&C Red No. 40, aluminum oxide, FD&C Blue No. 2, indigotindisulfonate sodium

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-7220 Teva Pharmaceuticals USA, Inc.
68071-0181 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.